TY - UNPB
T1 - The role of multidimensional poverty in antibiotic misuse
T2 - a study of self-medication and non-adherence in Kenya, Tanzania, and Uganda
AU - Green, Dominique L.
AU - Keenan, Katherine
AU - Huque, Sarah I.
AU - Kesby, Mike
AU - Mushi, Martha F.
AU - Kansiime, Catherine
AU - Asiimwe, Benon
AU - Kiiru, John
AU - Mshana, Stephen E.
AU - Neema, Stella
AU - Mwanga, Joseph R.
AU - Fredricks, Kathryn J.
AU - Lynch, Andy G.
AU - Worthington, Hannah
AU - Olamijuwon, Emmanuel
AU - Ahad, Mary Abed Al
AU - Aduda, Annette
AU - Mmbaga, Blandina T.
AU - Bazira, Joel
AU - Sandeman, Alison
AU - Stelling, John
AU - Gillespie, Stephen Henry
AU - Kibiki, Gibson
AU - Sabiti, Wilber
AU - Sloan, Derek J.
AU - Holden, Matthew T. G.
AU - Consortium, Hatua
N1 - Funding Information: UK National Institute for Health Research, Medical Research Council and the Department of Health and Social Care.
PY - 2021
Y1 - 2021
N2 - Background: Poverty is a proposed driver of antimicrobial resistance (AMR), influencing inappropriate antibiotic (AB) use in low and middle-income countries (LMICs). However, at sub-national levels, studies investigating poverty and AB use are sparse and the results inconsistent.Methods: The Holistic Approach to Unravelling Antimicrobial Resistance (HATUA) Consortium collected data from 6,827 patients presenting with urinary tract infection (UTI) symptoms in Kenya, Uganda, and Tanzania. Using Bayesian hierarchical modelling, we investigated the association between multidimensional poverty and self-reported AB self-medication and treatment non-adherence (skipping a dose and not completing the course). We also analysed linked qualitative in-depth patient interviews (IDIs) (n = 82) and unlinked focus group discussions (FGDs) with community members (n = 44 groups).Findings: AB self-medication and non-adherence to treatment courses was significantly more common in the least deprived group compared with those in severe poverty. Adjustment for AB ‘knowledge’, attitudes and socio-demographics diminished the association with self-medication, but not non-adherence. IDIs and FGDs suggested that self-medication and non-adherence are driven by perceived inconvenience of the healthcare system, financial barriers, and ease of unregulated AB access.Interpretation: Structural barriers to optimal AB use exist at all levels of the socioeconomic hierarchy. Inefficiencies in public healthcare may be fuelling alternative antibiotic access points, for those who can afford it. In designing interventions to tackle AMR and reduce AB misuse, the behaviours and needs of wealthier population groups should not be neglected.Funding Information: UK National Institute for Health Research, Medical Research Council and the Department of Health and Social Care.
AB - Background: Poverty is a proposed driver of antimicrobial resistance (AMR), influencing inappropriate antibiotic (AB) use in low and middle-income countries (LMICs). However, at sub-national levels, studies investigating poverty and AB use are sparse and the results inconsistent.Methods: The Holistic Approach to Unravelling Antimicrobial Resistance (HATUA) Consortium collected data from 6,827 patients presenting with urinary tract infection (UTI) symptoms in Kenya, Uganda, and Tanzania. Using Bayesian hierarchical modelling, we investigated the association between multidimensional poverty and self-reported AB self-medication and treatment non-adherence (skipping a dose and not completing the course). We also analysed linked qualitative in-depth patient interviews (IDIs) (n = 82) and unlinked focus group discussions (FGDs) with community members (n = 44 groups).Findings: AB self-medication and non-adherence to treatment courses was significantly more common in the least deprived group compared with those in severe poverty. Adjustment for AB ‘knowledge’, attitudes and socio-demographics diminished the association with self-medication, but not non-adherence. IDIs and FGDs suggested that self-medication and non-adherence are driven by perceived inconvenience of the healthcare system, financial barriers, and ease of unregulated AB access.Interpretation: Structural barriers to optimal AB use exist at all levels of the socioeconomic hierarchy. Inefficiencies in public healthcare may be fuelling alternative antibiotic access points, for those who can afford it. In designing interventions to tackle AMR and reduce AB misuse, the behaviours and needs of wealthier population groups should not be neglected.Funding Information: UK National Institute for Health Research, Medical Research Council and the Department of Health and Social Care.
KW - Multidimensional poverty
KW - Antibiotic misuse
KW - AMR
KW - LMICs
U2 - 10.2139/ssrn.3938836
DO - 10.2139/ssrn.3938836
M3 - Preprint
T3 - SSRN Electronic Journal
BT - The role of multidimensional poverty in antibiotic misuse
ER -